FBI Probes Jim Irsay Death
Analysis based on 9 articles · First reported Jan 22, 2026 · Last updated Jan 23, 2026
The investigation into Jim Irsay's death, particularly concerning the prescription of Ketamine and Opioid by Harry Haroutunian, could lead to increased scrutiny and potential regulatory changes in the pharmaceutical and addiction treatment industries. This event may also negatively impact the reputation of the United States — Indianapolis, although they have not been directly implicated in any wrongdoing.
The United States — Federal Bureau of Investigation has launched an investigation into the death of former United States — Indianapolis owner Jim Irsay, who died in May at 65. The probe focuses on the circumstances surrounding his death, his substance use, and his relationship with addiction recovery specialist Harry Haroutunian. Haroutunian, who was treating Jim Irsay with Ketamine and Opioid, signed Jim Irsay's death certificate, listing cardiac arrest due to pneumonia and heart issues as the cause, with no autopsy performed. Reports indicate that Jim Irsay received alarming amounts of prescription drugs from Harry Haroutunian, leading to overdoses in late 2023. The United States — Indianapolis are aware of the investigation but have not been contacted directly. The United States — Drug Enforcement Administration is assisting the United States — Federal Bureau of Investigation in the inquiry. The case draws parallels to the death of Matthew Perry, also linked to Ketamine.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard